Lankenau has been a leader in heart surgery since the 1960s. Our
internationally respected specialists use the latest minimally invasive
surgical approaches to deliver exceptional care to patients throughout
the region. These include advanced laparoscopic, endoscopic and
robotic procedures for the surgical treatment of coronary artery
disease, valvular disease, aortic disease, congenital defects/diseases
and rhythm disturbances.
Team Lankenau Medical Center is home
to some of the country’s foremost experts in the areas of robotic and
minimally invasive heart surgery. Our cardiac surgery team is lead
by Drs. Scott Goldman and Francis Sutter.
Approach As leaders in minimally
invasive heart surgery, the Lankenau Heart Institute team has particular
expertise in performing robotic-assisted coronary artery bypass graft
(CABG), endoscopic mitral valve repair surgery, minimally invasive
aortic valve replacement and transcatheter aortic valve
replacement. Innovative approaches such as these have led
Lankenau to consistently score above the Society of Thoracic Surgeons’
national average in CABG and valve surgical volumes. The latest 2010
published report by the Pennsylvania Health Care Cost Containment
Council, reported that “once again” Lankenau demonstrated “Less than
Expected Readmissions” for patients receiving either CABG or valve
By combining cutting-edge techniques with a multidisciplinary team
approach, the nationally renowned cardiac surgeons and specialists of
the Lankenau Heart Institute are achieving exceptional patient outcomes
and setting the national standard for heart care.
In most cases, a minimally invasive approach to heart surgery decreases
overall trauma to the body by eliminating the more invasive, open
Compared to traditional surgery, the benefits of minimally invasive and
robotic heart surgery include:
Shorter hospital stays usually 3-4 days and faster
Smaller incisions with minimal scarring and less pain
Maintained strength and independence
Quicker return to normal daily activities, including
work. The patient can resume activities without
restrictions including driving, if they feel up to it.
Clinical Trials Lankenau Heart
Institute’s cardiovascular surgeons are committed to providing patients
with individualized care, and combine clinical
research, options for experimental therapies and cutting-edge
technologies to achieve the best outcomes.
Since 1997, Lankenau has performed more than 1,000
endoscopic mitral valve repairs and 1,000
robotic-assisted CABG surgeries.
Dr. Goldman brings nationally renowned expertise in
mitral valve repair and aortic valve replacement to
Lankenau and performs 90 percent of his surgeries using
a minimally invasive approach.
Dr. Sutter is a national leader in minimally
invasive, robotic-assisted bypass surgery. He has
performed over 1,000 of these procedures, more than any
other surgeon in the country. He uses this
approach to treat approximately 70 percent of his
Dr. Sutter is the only surgeon in the Philadelphia
region who has perfected the minimally invasive,
robotic-assisted bypass procedure using just a single
Nearly 100 percent of all CABG surgeries (both open and
robotic-assisted) at Lankenau are performed without
stopping the heart and the use of a heart/lung bypass
machine. The national average is 19.4 percent.
81 percent of mitral valves are repaired at Lankenau,
compared to 57 percent nationally.
More than 81 percent of isolated aortic valve
replacement surgeries are performed at Lankenau using a
minimally invasive approach* .
Surgeons from around the world frequently come to
Lankenau to observe techniques and train under Dr.
Sutter and Dr. Goldberg.
For more information, call 1.866.CALL.MLH.